Imaging approach illuminates how weight loss drugs target the brain and pancreas

An international research team from Leibniz-FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular dual agonist drugs like tirzepatide interact with cells in the pancreas and brain. Published this week in Nature Metabolism, the findings could support the design of more effective treatments for diabetes and obesity.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup